We are live on
!
Find out more
IP
Isthmus Partners Portfolio holdings
AUM
$1.03B
1-Year Est. Return
22.86%
This Fund
S&P 500
This Quarter
Est. Return
+4.64%
1 Year Est. Return
+22.86%
3 Year Est. Return
+61.07%
5 Year Est. Return
+76.25%
10 Year Est. Return
+352.5%
AUM
$304M
AUM Growth
+$4.41M
(+1.5%)
Cap. Flow
-$6.35M
Cap. Flow
% of AUM
-2.09%
Top 10 Holdings %
Top 10 Hldgs %
23.43%
Holding
253
New
2
Increased
22
Reduced
99
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
IQVIA
IQV
|
+$5.64M |
| 2 |
BSTC
BioSpecifics Technologies Corp.
BSTC
|
+$637K |
| 3 |
ARLZ
Aralez Pharmaceuticals Inc.
ARLZ
|
+$234K |
| 4 |
IRIDEX
IRIX
|
+$175K |
| 5 |
SLB Ltd
SLB
|
+$149K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
VAL
Valspar
VAL
|
+$7.01M |
| 2 |
CLR
CONTINENTAL RESOURCES INC.
CLR
|
+$663K |
| 3 |
MASI
Masimo
MASI
|
+$615K |
| 4 |
TFM
THE FRESH MARKET, INC COM STK
TFM
|
+$561K |
| 5 |
Charles River Laboratories
CRL
|
+$290K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.45% |
| 2 | Industrials | 18.46% |
| 3 | Technology | 16.64% |
| 4 | Financials | 11.78% |
| 5 | Consumer Staples | 6.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
WIN
51
DELISTED
Windstream Holdings Inc
WIN
| $910K | 0.3% |
19,640
-932
| -5% | -$39.7K |
|
52
Exponent
EXPO
$3.04B
| $893K | 0.29% |
30,588
-916
| -3% | -$23.8K |
|
53
Procter & Gamble
PG
$346B
| $888K | 0.29% |
10,493
-607
| -5% | -$49.8K |
|
54
Anika Therapeutics
ANIK
$200M
| $874K | 0.29% |
16,288
-453
| -3% | -$21.3K |
|
55
RLI Corp
RLI
$5.88B
| $837K | 0.28% |
24,346
-732
| -3% | -$23.8K |
|
56
Insteel Industries
IIIN
$624M
| $824K | 0.27% |
28,825
-1,009
| -3% | -$28.5K |
|
57
Gartner
IT
$9.87B
| $824K | 0.27% |
8,460
-231
| -3% | -$22K |
|
|
WBA
58
DELISTED
Walgreens Boots Alliance
WBA
| $819K | 0.27% |
9,837
| – | – |
|
59
Ligand Pharmaceuticals
LGND
$5.96B
| $805K | 0.26% |
10,814
-401
| -4% | -$29.8K |
|
|
SYKE
60
DELISTED
SYKES Enterprises Inc
SYKE
| $759K | 0.25% |
26,217
-783
| -3% | -$23K |
|
|
CLCT
61
DELISTED
Collectors Universe
CLCT
| $743K | 0.24% |
37,627
-715
| -2% | -$13.2K |
|
62
Union Pacific
UNP
$178B
| $742K | 0.24% |
8,500
-900
| -10% | -$76.1K |
|
63
Strategy Inc
MSTR
$36B
| $741K | 0.24% |
42,360
-1,250
| -3% | -$23K |
|
64
Dorman Products
DORM
$4.08B
| $734K | 0.24% |
12,833
-241
| -2% | -$12.9K |
|
65
Stock Yards Bancorp
SYBT
$2.43B
| $724K | 0.24% |
25,641
-579
| -2% | -$15.7K |
|
|
KMG
66
DELISTED
KMG Chemicals Inc
KMG
| $722K | 0.24% |
27,778
-288
| -1% | -$6.71K |
|
67
PetMed Express
PETS
$42.1M
| $713K | 0.23% |
37,992
-979
| -3% | -$18K |
|
|
PRXL
68
DELISTED
Parexel International Corp
PRXL
| $703K | 0.23% |
11,174
-237
| -2% | -$14.7K |
|
69
Tetra Tech
TTEK
$8.28B
| $695K | 0.23% |
113,000
-1,530
| -1% | -$9.15K |
|
|
BSTC
70
DELISTED
BioSpecifics Technologies Corp.
BSTC
| $695K | 0.23% |
+17,395
| New | +$637K |
|
71
Fox Factory Holding Corp
FOXF
$779M
| $686K | 0.23% |
39,512
-712
| -2% | -$12K |
|
72
1st Source
SRCE
$2.09B
| $685K | 0.23% |
21,153
-548
| -3% | -$18.1K |
|
|
MSCC
73
DELISTED
Microsemi Corp
MSCC
| $684K | 0.23% |
20,919
-477
| -2% | -$16.3K |
|
74
Culp Inc
CULP
$45.5M
| $671K | 0.22% |
24,299
-344
| -1% | -$9.37K |
|
75
Independent Bank
INDB
$4.03B
| $671K | 0.22% |
14,678
-302
| -2% | -$14.1K |
|
Similar funds
CM
CFFNO
RIM
TBA
JSC
MGWM
MSIIA
NFG
Isthmus Partners's Q2 2016 Portfolio in Review
As of Q2 2016, Isthmus Partners held 253 positions worth $304M, up 1.5% from $300M the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Trading was light in Q2 2016: portfolio turnover was 2.8%. Isthmus Partners opened 2 new positions and exited 5, leaving the 253-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 20% a quarter earlier, followed by Industrials and Technology.
- Isthmus Partners's largest Q2 2016 buy was IQVIA: 84,231 shares worth $5.5M.
- Isthmus Partners added most to Aralez Pharmaceuticals Inc. in Q2 2016, an estimated $234K increase.
- Isthmus Partners's biggest Q2 2016 reduction was Valspar, cutting an estimated $7.01M.
- Isthmus Partners fully exited THE FRESH MARKET, INC COM STK in Q2 2016, selling an estimated $561K.
- Isthmus Partners's ten largest holdings make up 23% of its $304M portfolio in Q2 2016.
- Isthmus Partners opened 2 new positions and closed 5 in Q2 2016.
- Isthmus Partners's portfolio value rose 1.5% quarter-over-quarter to $304M.
Based on Isthmus Partners's 13F filing for Q2 2016, filed 8 Aug 2016.